Standard care often overlooks how differences in the gut microbiome influence disease risk, symptoms, and treatment response.
R&D Focus
Microbiome diagnostics, monitoring, and precision therapeutics
Innovative Solution
Biomatz is a biotechnology company specializing in microbiome therapeutics. Their proprietary platform designs cooperative microbial consortia by isolating and analyzing complex gut microbiota interactions, facilitating the development of live biotherapeutic products.
Investment Funding
Last Funding Stage
Seed
Total Funding Amount
1.53M
Last Funding Amount
1.53M
Last Funding Date
28-06-2023
Startup Stage
Seed
Lead Investors
Korea Investment Partners, Daewoong Pharmaceutical, Korea Kolmar Co., Gyeongnam Venture Investment
About
Biomatz is a biotechnology company specializing in microbiome therapeutics. Their proprietary platform designs cooperative microbial consortia by isolating and analyzing complex gut microbiota interactions, facilitating the development of live biotherapeutic products. It aims to advance personalized medicine and gut health solutions with applications spanning pharmaceuticals, nutraceuticals, and functional foods.​
Products
Demo Product or Complete Product?
Development stage
Something missing or incorrect on this page? Help us enrich this information
